Hydroxyapatite (HA) crystallinity is measured by X-ray diffraction (XRD) under ISO 13779 by separating crystalline peak intensity from amorphous background scatter in a diffractogram. The crystalline portion is expressed as a percentage of total scatter. This article covers the diffraction principle, sample preparation, instrument parameters, calculation, validation, and how the result fits the implant coating test program.
Principle & mechanism
XRD crystallinity measurement rests on Bragg diffraction. A collimated X-ray beam strikes the sample. Crystal planes with a given interplanar spacing diffract the beam at angles satisfying Bragg's law. Well-ordered apatite lattices produce sharp reflections. The (002) and (211) peaks of hydroxyapatite are the most diagnostic. Amorphous calcium phosphate lacks long-range order. It contributes only broad humps in the background between roughly 20° and 35° two-theta. Crystallinity is quantified by separating the coherent peak intensity of the crystalline phase from the diffuse scattering of the amorphous fraction. The crystalline portion is then expressed as a percentage of total scatter. The method also distinguishes hydroxyapatite from secondary phases such as tricalcium phosphate, tetracalcium phosphate, and calcium oxide. These phases affect both dissolution behavior and compliance with the phase-purity requirements of the ISO 13779 series.
Sample preparation and powder handling
ISO 13779 differentiates between powder feedstock and finished coatings, and preparation differs accordingly. For powders, a representative portion is ground gently in an agate mortar. This breaks agglomerates without introducing lattice strain. The powder is then back-loaded or side-drifted into a holder to minimize preferred orientation of the platy apatite crystallites. Coated coupons are measured as-received after degreasing with a suitable solvent. The coating surface must remain unaltered, because etching or polishing can change the apparent crystalline fraction. Where the coating is thin, care is taken to keep the X-ray penetration volume within the layer. This prevents substrate reflections, typically from titanium alloy, from contaminating the pattern. Samples are logged, photographed, and conditioned in a desiccator, since adsorbed moisture raises the background. Powder samples retained from the same batch also serve the chemical composition and Ca/P ratio analyses described elsewhere in the ISO 13779-2 testing scope.
XRD measurement procedure and parameters
A typical measurement uses a benchtop or floor-standing powder diffractometer with copper K-alpha radiation, Bragg-Brentano geometry, and a scintillation or position-sensitive detector. A common scanning range spans 10° to 60° two-theta. This covers the diagnostic apatite reflections and the main secondary-phase peaks. Step size is kept small, on the order of a few hundredths of a degree. Counting time per step is sufficient so that weak amorphous humps are resolved above statistical noise. The generator operates at standard tube power for the instrument class. A calibrated standard such as silicon or corundum is run periodically to verify angle accuracy and intensity stability. Samples spin during acquisition to average grain-size effects. Documentation covers instrument identification, scan conditions, and any deviations. The resulting diffractogram is then carried forward to the crystallinity calculation. The full pattern is archived alongside the coating adhesion and thickness records for the same batch.
Crystallinity
calculation and data processing
Processing begins with background subtraction and, where required, K-alpha-2 stripping. The analyst integrates the crystalline peak area. This is most commonly the region containing the (211), (112), and (300) reflections. The analyst also measures the amorphous area under the broad halo between selected boundary angles. Crystallinity is reported as the crystalline intensity divided by the sum of crystalline and amorphous intensities, expressed as a percentage. Peak positions are matched against reference patterns for hydroxyapatite and possible impurity phases. Any tricalcium phosphate or calcium oxide reflections are flagged and, if quantified, compared against the phase limits stated in the ISO 13779 series. Peak width, reported as full width at half maximum, gives an additional indication of crystallite size and lattice strain. Commercial and open-source refinement software can fit the profile more rigorously. For routine release testing, however, the peak-area ratio method remains the accepted approach. All calculations are traceable to raw data files.
Precision,
repeatability, and method validation
Crystallinity is a ratio derived from two intensity regions. Precision therefore depends on counting statistics, background placement, and boundary-angle selection. Laboratories establish repeatability by measuring one representative specimen multiple times within a run and across different days. The standard deviation of the crystallinity value is reported. Reproducibility is checked by rotating or re-mounting the specimen, since packing and surface texture influence the amorphous halo. Validation activities documented in the quality system include angle calibration with a certified standard, linearity of response, and defined acceptance windows for reference-material checks. Uncertainty contributions from step time, sample displacement, and overlap of adjacent peaks are evaluated and combined. The same validation discipline applied to tensile pull-off adhesion testing and shear testing of the coating applies here. Control charts track drift, and out-of-control trigger points halt reporting. Records allow the client to trace every reported percentage back to instrument conditions and raw scans.
Applications
in medical device and implant testing
Crystallinity data support regulatory submissions and batch release for plasma-sprayed hydroxyapatite coatings on hip stems, dental fixtures, and spinal devices. The measurement indicates expected dissolution behavior. Low crystallinity signals faster resorption, which can compromise fixation. Excessive secondary phases suggest process drift in the spray line. Within a full ISO 13779 program, XRD sits alongside coating thickness measurement, composition and purity analysis, and dissolution testing. Together these give a coherent picture of coating quality. The result also feeds risk assessments under biocompatibility testing per ISO 10993, since coating degradation products contact tissue directly. Manufacturers of rotating implant-bearing components similarly combine material verification with functional checks such as bearing vibration testing to ISO 15242. Fatigue life validation per ISO 281 demonstrates the mechanical durability of the assembled device. Crystallinity thus anchors the material-level evidence within a layered verification strategy.
Frequently Asked Questions
Which
hydroxyapatite products can undergo XRD crystallinity testing per ISO 13779?
The method applies to hydroxyapatite coating powders, coated implant coupons such as hip stems and dental fixtures, and sintered or granular calcium phosphate materials. Powder feedstock and finished coatings are the two routine sample forms. The coating must be intact and the surface must not have been altered by polishing or etching.
What
does an ISO 13779 XRD crystallinity report contain and when is it used?
A typical report presents the diffractogram, the calculated crystallinity percentage, identified phases such as hydroxyapatite and any secondary calcium phosphate phases, plus instrument and scan parameters. It is used for regulatory submissions, batch release, spray-process control, and material verification within a broader coating test program.
How should a client submit samples and what communication points matter?
Clients should state whether powders or coated coupons are supplied. They should declare the substrate and nominal coating thickness. They should also indicate whether other ISO 13779 tests such as adhesion or composition analysis are needed on the same batch. Agreeing scan range, reporting format, and turnaround in advance avoids re-testing and keeps material traceability intact.